$2.01 -0.06 (-2.94%)

Opus Genetics, Inc. Common Stock (IRD)

Opus Genetics, Inc. is a biotechnology company focused on pioneering gene therapies and innovative treatments for genetic disorders. The company leverages advanced genomic technologies to develop targeted solutions aimed at improving patient outcomes and addressing unmet medical needs in the genetic medicine space.

🚫 Opus Genetics, Inc. Common Stock does not pay dividends

Company News

Opus Genetics to Participate in Chardan's 9th Annual Genetic Medicines Conference
GlobeNewswire Inc. • Opus Genetics, Inc. • October 14, 2025

Opus Genetics will present a corporate update at Chardan's 9th Annual Genetic Medicines Conference, highlighting their gene therapies for inherited retinal diseases and ongoing clinical trials for treatments like OPGx-LCA5 and OPGx-BEST1.

Top 10 Small-Cap Stocks to Watch in 2025
Investing.com • Professor Ari Zoldan • December 20, 2024

The article discusses 10 small-cap stocks that could outperform in 2025, citing factors like falling interest rates, low valuations, and potential shifts in industrial production.

AUNACNTXEVGOEVGOWFFICCRGO